Profile photo Roger Schutgens

Roger Schutgens

Full Professor

Strategic program(s):

Biography

Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Research groups

Thrombosis and hemostasis

Research aim

We aim to advance knowledge in the field of thrombosis and hemostasis and translate scientific findings into improved clinical care and outcomes for patients affected by blood clotting disorders.
Go to group

Hemophilia, Von Willebrand disease and allied coagulation disorders

Research aim

To improve care for patients with (inherited) bleeding disorders by studying the optimum outcome parameters in a multidisciplinary setting, including physiotherapy and nursing interventions, as well as novel treatment modalities.
Go to group

Recent publications

Limited value of testing for factor XIII and α2-antiplasmin deficiency in patients with a bleeding disorder of unknown cause Sander Ariëns, Albert Huisman, Idske C L Kremer Hovinga, Rolf T Urbanus, Karin P M van Galen, Lize F D van Vulpen, Kathelijn Fischer, Roger E G Schutgens
Haemophilia, 2024, vol. 30, p.998-1002
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease Myrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, Minke A E Rab, Brigitte A van Oirschot, Jennifer Bos, Cleo Derichs, Anita W Rijneveld, Marjon H Cnossen, Erfan Nur, Bart J Biemond, Marije Bartels, Roger E G Schutgens, Wouter W van Solinge, Judith J M Jans, Eduard J van Beers, Richard van Wijk
Hemasphere, 2024, vol. 8
Functional decline in persons with haemophilia and factors associated with deterioration Johan Blokzijl, Martijn F Pisters, Cindy Veenhof, Roger E G Schutgens, Merel A Timmer
Haemophilia, 2023, vol. 29, p.790-798
Heavy menstrual bleeding in adolescents Stella J. Van ‘t Klooster, Anne de Vaan, Jeanette van Leeuwen, Lynnda Pekel, Nathalie M. van Rijn-van Kortenhof, Eveline T. Engelen, Willie van Greevenbroek, Albert Huisman, Kathelijn Fischer, Roger E.G. Schutgens, Karin P.M. van Galen
Research and practice in thrombosis and haemostasis, 2023, vol. 7
Structural changes after ankle joint distraction in haemophilic arthropathy Eline D P van Bergen, Simon C Mastbergen, Floris P J G Lafeber, Anne-Christine Bay-Jensen, Sofie F Madsen, Helena Port, Wouter Foppen, Roger E G Schutgens, Mylène P Jansen, Lize F D van Vulpen
Haemophilia, 2023, vol. 29, p.874-882
DOSEMI-STUDIE Konrad van der Zwet, Anouk Donners, Toine Egberts, Lize van Vulpen, Roger E Schutgens, RT Urbanus, K Fischer
Nederlands Tijdschrift voor Hematologie, 2023, vol. 20, p.352–5

Fellowships & Awards

2017: Immune tolerance induction (ITI) in Hemophilia A: Role for rFVIII-Fc in inducing tolerance

External positions

1% maatschapsaandeel - geen - Huisartsenpraktijk Voordorp

zie bijlage - inhoudsdeskundige - Zorginstituut Nederland